Anti-EGFR x Anti-IGF1R Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-EGFR and anti-IGF1R parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Colorectal cancer; Cervical cancer; Breast cancer; Pancreatic cancer therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY